Intelligent Bio Solutions Inc.
INBS
$2.40
$0.051.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.61M | -11.29M | -10.87M | -10.57M | -10.26M |
| Total Depreciation and Amortization | 1.18M | 1.19M | 1.21M | 1.21M | 1.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 719.50K | 769.80K | 734.60K | 398.60K | 211.50K |
| Change in Net Operating Assets | -1.24M | -43.50K | -1.22M | -720.90K | -1.56M |
| Cash from Operations | -10.95M | -9.38M | -10.14M | -9.68M | -10.41M |
| Capital Expenditure | -334.20K | -361.50K | -302.20K | -231.80K | -190.60K |
| Sale of Property, Plant, and Equipment | 40.20K | 40.20K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -294.10K | -321.40K | -302.20K | -231.80K | -190.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.27M | 8.16M | 8.11M | 4.60M | 4.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.27M | 8.16M | 8.11M | 4.60M | 4.00M |
| Foreign Exchange rate Adjustments | 30.40K | 42.90K | -3.60K | 27.20K | 10.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.06M | -1.50M | -2.33M | -5.28M | -6.59M |